Found: 12
Select item for more details and to access through your institution.
Acute and delayed toxicity of gemcitabine administered during isolated lung perfusion: a preclinical dose-escalation study in pigs.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2015, v. 48, n. 2, p. 228, doi. 10.1093/ejcts/ezu441
- By:
- Publication type:
- Article
HER2-Low Luminal Breast Carcinoma Is Not a Homogenous Clinicopathological and Molecular Entity.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 2009, doi. 10.3390/cancers16112009
- By:
- Publication type:
- Article
Custom multi-tumor next-generation sequencing panel for routine molecular diagnosis of solid tumors: Validation and results from three-year clinical use.
- Published in:
- International Journal of Molecular Medicine, 2022, v. 49, n. 5, p. N.PAG, doi. 10.3892/ijmm.2022.5113
- By:
- Publication type:
- Article
Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using F-FDG PET in luminal HER2-negative breast cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 3, p. 416, doi. 10.1007/s00259-013-2616-3
- By:
- Publication type:
- Article
Superficial CD34‐positive fibroblastic tumor and PRDM10‐rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases.
- Published in:
- Histopathology, 2021, v. 79, n. 5, p. 810, doi. 10.1111/his.14429
- By:
- Publication type:
- Article
Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers.
- Published in:
- 2018
- By:
- Publication type:
- journal article
ER−/PR+ breast cancer: A distinct entity, which is morphologically and molecularly close to triple‐negative breast cancer.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 1, p. 200, doi. 10.1002/ijc.33539
- By:
- Publication type:
- Article
Anticipating changes in the HER2 status of breast tumours with disease progression—towards better treatment decisions in the new era of HER2-low breast cancers.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 122, doi. 10.1038/s41416-023-02287-x
- By:
- Publication type:
- Article
Radiotherapy Scheme Effect on PD-L1 Expression for Locally Advanced Rectal Cancer.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 9, p. 2071, doi. 10.3390/cells9092071
- By:
- Publication type:
- Article
Real-World Experience of Efficacy and Safety of Trabectedin in Patients with Soft Tissue Sarcoma: A Bicentric Retrospective Analysis.
- Published in:
- Oncology, 2022, v. 100, n. 12, p. 633, doi. 10.1159/000527602
- By:
- Publication type:
- Article
Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic NSCLC.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1437961
- By:
- Publication type:
- Article
PEC‐PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 13, p. 2304, doi. 10.1002/cncr.35277
- By:
- Publication type:
- Article